Abstract
P-319 Efficacy and safety of daratumumab with ixazomib and dexamethasone in lenalidomide-exposed patients after one prior line of therapy: final results of the Phase 2 study DARIA
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have